ArticleBMC cancer2026

Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study.

Feng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.